Comments
Loading...

GE HealthCare Techs Analyst Ratings

GEHCNASDAQ
Logo brought to you by Benzinga Data
$72.55
0.660.92%
After Hours: 9:30 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$110.00
Lowest Price Target1
$73.00
Consensus Price Target1
$92.29

GE HealthCare Techs Analyst Ratings and Price Targets | NASDAQ:GEHC | Benzinga

GE HealthCare Technologies Inc has a consensus price target of $92.29 based on the ratings of 19 analysts. The high is $110 issued by Argus Research on April 1, 2024. The low is $73 issued by UBS on May 5, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, UBS, and Goldman Sachs on May 6, 2025, May 5, 2025, and May 1, 2025, respectively. With an average price target of $77.67 between Morgan Stanley, UBS, and Goldman Sachs, there's an implied 8.68% upside for GE HealthCare Technologies Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
2
Feb
1
Mar
2
Apr
3
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
UBS
Goldman Sachs
Wells Fargo
Evercore ISI Group

1calculated from analyst ratings

Analyst Ratings for GE HealthCare Techs

Buy NowGet Alert
05/06/2025Buy Now9.14%Morgan Stanley
Patrick Wood50%
$86 → $78MaintainsEqual-WeightGet Alert
05/05/2025Buy Now2.15%UBS
Graham Doyle42%
$74 → $73UpgradeSell → NeutralGet Alert
05/01/2025Buy Now14.74%Goldman Sachs
David Roman39%
$94 → $82MaintainsBuyGet Alert
05/01/2025Buy Now24.54%Wells Fargo
Larry Biegelsen65%
$103 → $89MaintainsOverweightGet Alert
05/01/2025Buy Now18.94%Evercore ISI Group
Vijay Kumar50%
$96 → $85MaintainsOutperformGet Alert
04/30/2025Buy Now20.34%Citigroup
Joanne Wuensch74%
$105 → $86MaintainsBuyGet Alert
04/23/2025Buy Now23.14%Piper Sandler$104 → $88MaintainsOverweightGet Alert
03/11/2025Buy Now39.93%Goldman Sachs
David Roman39%
$85 → $100UpgradeNeutral → BuyGet Alert
02/14/2025Buy Now44.13%Wells Fargo
Larry Biegelsen65%
$96 → $103MaintainsOverweightGet Alert
02/13/2025Buy Now53.92%Citigroup
Joanne Wuensch74%
$103 → $110MaintainsBuyGet Alert
01/08/2025Buy Now44.13%Jefferies
Matthew Taylor70%
$95 → $103UpgradeHold → BuyGet Alert
10/31/2024Buy Now34.33%Wells Fargo
Larry Biegelsen65%
$95 → $96MaintainsOverweightGet Alert
10/01/2024Buy Now42.73%Evercore ISI Group
Vijay Kumar50%
$98 → $102MaintainsOutperformGet Alert
09/30/2024Buy Now42.73%Stifel
Rick Wise73%
$100 → $102MaintainsBuyGet Alert
09/26/2024Buy Now3.55%UBS
Graham Doyle42%
$84 → $74DowngradeNeutral → SellGet Alert
09/18/2024Buy Now39.93%BTIG
Ryan Zimmerman70%
→ $100UpgradeNeutral → BuyGet Alert
09/09/2024Buy Now25.94%JP Morgan
Robbie Marcus65%
→ $90Initiates → NeutralGet Alert
08/06/2024Buy Now39.93%Stifel
Rick Wise73%
→ $100Initiates → BuyGet Alert
07/02/2024Buy Now17.54%UBS
Graham Doyle42%
$88 → $84MaintainsNeutralGet Alert
05/30/2024Buy Now21.74%Goldman Sachs
David Roman39%
→ $87Initiates → NeutralGet Alert
05/01/2024Buy Now20.34%B of A Securities
Craig Bijou77%
$94 → $86MaintainsNeutralGet Alert
05/01/2024Buy Now46.93%Mizuho
Anthony Petrone64%
$110 → $105MaintainsBuyGet Alert
04/11/2024Buy Now53.92%Mizuho
Anthony Petrone64%
$96 → $110MaintainsBuyGet Alert
04/04/2024Buy Now39.93%Evercore ISI Group
Vijay Kumar50%
$93 → $100MaintainsOutperformGet Alert
04/03/2024Buy Now44.13%Citigroup
Joanne Wuensch74%
$88 → $103MaintainsBuyGet Alert
04/01/2024Buy Now53.92%Argus Research
David Toung68%
$80 → $110MaintainsBuyGet Alert
02/15/2024Buy Now39.93%HSBC
Sezgi Oezener33%
→ $100Initiates → BuyGet Alert
02/12/2024Buy Now20.34%Morgan Stanley
Patrick Wood50%
$74 → $86MaintainsEqual-WeightGet Alert
02/12/2024Buy Now23.14%UBS
Graham Doyle42%
$66 → $88UpgradeSell → NeutralGet Alert
02/07/2024Buy Now34.33%Mizuho
Anthony Petrone64%
$94 → $96MaintainsBuyGet Alert
12/04/2023Buy Now3.55%Morgan Stanley
Patrick Wood50%
$78 → $74MaintainsEqual-WeightGet Alert
11/30/2023Buy Now11.94%Jefferies
Matthew Taylor70%
→ $80Initiates → HoldGet Alert
11/27/2023Buy Now-7.65%UBS
Graham Doyle42%
$86 → $66DowngradeNeutral → SellGet Alert
09/19/2023Buy Now14.74%Citigroup
Joanne Wuensch74%
→ $82Initiates → BuyGet Alert
08/16/2023Buy Now25.94%Wells Fargo
Larry Biegelsen65%
→ $90Initiates → OverweightGet Alert
07/31/2023Buy Now14.74%B of A Securities
Craig Bijou77%
→ $82Initiates → NeutralGet Alert
07/26/2023Buy Now9.14%Morgan Stanley
Patrick Wood50%
$76 → $78MaintainsEqual-WeightGet Alert
06/28/2023Buy Now6.35%Morgan Stanley
Patrick Wood50%
→ $76Initiates → Equal-WeightGet Alert
06/27/2023Buy Now6.35%Morgan Stanley
Patrick Wood50%
→ $76Initiates → Equal-WeightGet Alert
05/16/2023Buy Now35.73%Oppenheimer
Suraj Kalia59%
→ $97Initiates → OutperformGet Alert
04/26/2023Buy Now31.53%Mizuho
Anthony Petrone64%
$92 → $94MaintainsBuyGet Alert
04/26/2023Buy Now20.34%UBS
Graham Doyle42%
→ $86Initiates → NeutralGet Alert
04/19/2023Buy Now32.93%Piper Sandler
Jason Bednar52%
→ $95Initiates → OverweightGet Alert
04/18/2023Buy Now28.73%Mizuho
Anthony Petrone64%
$90 → $92MaintainsBuyGet Alert
04/10/2023Buy NowBTIG
Ryan Zimmerman70%
Initiates → NeutralGet Alert
03/13/2023Buy Now25.94%Evercore ISI Group
Vijay Kumar50%
→ $90Initiates → OutperformGet Alert
02/17/2023Buy Now25.94%Mizuho
Anthony Petrone64%
→ $90Initiates → BuyGet Alert
01/19/2023Buy NowRedburn Partners
Ed Ridley-Day66%
Initiates → BuyGet Alert
01/04/2023Buy NowEdward Jones
John Boylan73%
Initiates → HoldGet Alert

FAQ

Q

What is the target price for GE HealthCare Techs (GEHC) stock?

A

The latest price target for GE HealthCare Techs (NASDAQ:GEHC) was reported by Morgan Stanley on May 6, 2025. The analyst firm set a price target for $78.00 expecting GEHC to rise to within 12 months (a possible 9.14% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for GE HealthCare Techs (GEHC)?

A

The latest analyst rating for GE HealthCare Techs (NASDAQ:GEHC) was provided by Morgan Stanley, and GE HealthCare Techs maintained their equal-weight rating.

Q

When was the last upgrade for GE HealthCare Techs (GEHC)?

A

The last upgrade for GE HealthCare Technologies Inc happened on May 5, 2025 when UBS raised their price target to $73. UBS previously had a sell for GE HealthCare Technologies Inc.

Q

When was the last downgrade for GE HealthCare Techs (GEHC)?

A

The last downgrade for GE HealthCare Technologies Inc happened on September 26, 2024 when UBS changed their price target from $84 to $74 for GE HealthCare Technologies Inc.

Q

When is the next analyst rating going to be posted or updated for GE HealthCare Techs (GEHC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE HealthCare Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE HealthCare Techs was filed on May 6, 2025 so you should expect the next rating to be made available sometime around May 6, 2026.

Q

Is the Analyst Rating GE HealthCare Techs (GEHC) correct?

A

While ratings are subjective and will change, the latest GE HealthCare Techs (GEHC) rating was a maintained with a price target of $86.00 to $78.00. The current price GE HealthCare Techs (GEHC) is trading at is $71.47, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch